M62.50
Conditions
Interventions
Group 1: sarcopenic patients are once questionned about the relative importance of 5 sarcopenia-related study outcomes for affected persons (mobility, quality of life, falls, activities of daily livin
Sponsors
Public Health, Epidemiology and Health Economics, CHU - Sart Tilman, Quartier Hôpital, University of Liège, Liège, Belgium
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: 65 years or older with sarcopenia, i.e. low muscle mass ((assessed with bioelectrical impedance analysis): skeletal muscle mass index (SMMI) = SMM [in kg] / (height [in m])² = 10,75 kg/m² (men) / = 6,75 kg/m² (women)) in combination with low muscle strength (hand grip strength (dynamometry) < 30 kg (men) bzw. < 20 kg (women)) and/or slow walking speed (< 0,8 m/s)
Exclusion criteria
Exclusion criteria: not sarcopenic, refusal or unable to give informed consent, contraindication for bioelecrical impedance analysis, diagnosis of dementia or severe cognitive impairment or unable to understand task, severe depression, unable to sufficiently speak or understand German
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the relative importance of 5 sarcopenia-related study outcomes for affected persons (mobility, quality of life, falls, activities of daily living, fatigue) by means of a discrete choice experiment (questionnaire with 13 scenarios) | — |
Secondary
| Measure | Time frame |
|---|---|
| differences in primary outcome between the 7 participating countries | — |
Countries
Belgium, France, Germany, Italy, Spain, Switzerland, United Kingdom
Contacts
Public ContactSabine Goisser
Agaplesion Bethanien-Krankenhaus, Geriatrisches Zentrum der Universität Heidelberg
Outcome results
None listed